We are live on ! Find out more
FMI

F/M Investments Portfolio holdings

AUM $1.97B
1-Year Est. Return 30.33%
This Fund
S&P 500
This Quarter Est. Return
-2.84%
1 Year Est. Return
+30.33%
3 Year Est. Return
+101.46%
5 Year Est. Return
+144.03%
10 Year Est. Return
AUM
$2.51B
AUM Growth
-$201M
Cap. Flow
-$78.6M
Cap. Flow %
-3.13%
Top 10 Hldgs %
32.12%
Holding
422
New
23
Increased
129
Reduced
193
Closed
31

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$11.8M
2
C icon
Citigroup
C
+$6.42M
3
BLK icon
Blackrock
BLK
+$5.5M
4
HUBS icon
HubSpot
HUBS
+$4.88M
5
LRCX icon
Lam Research
LRCX
+$4.71M

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 11.09%
3 Financials 10.98%
4 Consumer Discretionary 8.01%
5 Industrials 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QCOM icon
251
Qualcomm
QCOM
$176B
$1.67M 0.07%
10,852
-426
-4% -$69.4K
IEMG icon
252
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$1.65M 0.07%
30,610
+1,905
+7% +$103K
GH icon
253
Guardant Health
GH
$22.6B
$1.65M 0.07%
+38,628
New +$1.67M
EVRG icon
254
Evergy
EVRG
$19.2B
$1.6M 0.06%
23,244
+544
+2% +$35.6K
BRK.A icon
255
Berkshire Hathaway Class A
BRK.A
$1.12T
$1.6M 0.06%
2
MO icon
256
Altria Group
MO
$114B
$1.59M 0.06%
26,516
-1,175
-4% -$64.2K
KMB icon
257
Kimberly-Clark
KMB
$36.5B
$1.58M 0.06%
11,138
-44
-0.4% -$5.93K
ETNB
258
DELISTED
89bio
ETNB
$1.56M 0.06%
+214,837
New +$1.88M
AZN icon
259
AstraZeneca
AZN
$250B
$1.55M 0.06%
10,574
-467
-4% -$67.6K
KWR icon
260
Quaker Houghton
KWR
$2.92B
$1.55M 0.06%
12,511
+38
+0.3% +$5.16K
PLYM
261
DELISTED
Plymouth Industrial REIT
PLYM
$1.54M 0.06%
94,462
+322
+0.3% +$5.43K
VNQ icon
262
Vanguard Real Estate ETF
VNQ
$39B
$1.52M 0.06%
16,759
CMA
263
DELISTED
Comerica
CMA
$1.49M 0.06%
25,283
-1,188
-4% -$74.6K
IGSB icon
264
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$1.48M 0.06%
28,272
+1,061
+4% +$55.2K
ET icon
265
Energy Transfer Partners
ET
$69.3B
$1.45M 0.06%
77,933
CIEN icon
266
Ciena
CIEN
$58.4B
$1.45M 0.06%
23,913
+1,289
+6% +$102K
WHR icon
267
Whirlpool
WHR
$2.82B
$1.42M 0.06%
15,784
-142
-0.9% -$15.1K
CRDO icon
268
Credo Technology Group
CRDO
$46.6B
$1.42M 0.06%
35,260
-8,755
-20% -$544K
ALAB icon
269
Astera Labs
ALAB
$58B
$1.42M 0.06%
23,717
+1,065
+5% +$98.5K
CCI icon
270
Crown Castle
CCI
$32.2B
$1.39M 0.06%
13,337
-135
-1% -$12.6K
IVV icon
271
iShares Core S&P 500 ETF
IVV
$902B
$1.37M 0.05%
2,672
+800
+43% +$472K
LAMR icon
272
Lamar Advertising Co
LAMR
$16.3B
$1.31M 0.05%
+11,503
New +$1.4M
TM icon
273
Toyota
TM
$225B
$1.3M 0.05%
+7,346
New +$1.37M
DKS icon
274
Dick's Sporting Goods
DKS
$18.7B
$1.29M 0.05%
6,417
-285
-4% -$63.6K
IGIB icon
275
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
$1.2M 0.05%
22,866
+1,485
+7% +$77.1K

Similar funds

F/M Investments's Q1 2025 Portfolio in Review

As of Q1 2025, F/M Investments held 422 positions worth $2.51B, down 7.4% from $2.71B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

F/M Investments withdrew a net $78.6M in Q1 2025, closing 31 positions and reducing 193 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $3.08M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

Against the trend, F/M Investments opened a new position in Idexx Laboratories worth $11.4M.

  • F/M Investments's largest Q1 2025 buy was Idexx Laboratories: 27,178 shares worth $11.4M.
  • F/M Investments added most to Palantir in Q1 2025, an estimated $3.23M increase.
  • F/M Investments's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $18.7M.
  • F/M Investments fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $3.08M.
  • F/M Investments's ten largest holdings make up 32% of its $2.51B portfolio in Q1 2025.
  • F/M Investments opened 23 new positions and closed 31 in Q1 2025.
  • F/M Investments's portfolio value fell 7.4% quarter-over-quarter to $2.51B.

Based on F/M Investments's 13F filing for Q1 2025, filed 14 May 2025.